Northwest Biotherapeutics, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $117.0K | $6.9M | $21.8M | $13.4M | $18.5M | $7.3M | $24.0K | $153.0K |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $1.4M | $7.9M | $24.1M | $14.6M | $18.6M | $7.5M | $118.0K | $239.0K |
| Property, Plant & Equipment | $47.5M | $315.0K | $476.0K | $40.0M | $83.0K | $95.0K | $78.0K | $39.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $48.9M | $52.9M | $70.8M | $56.5M | $18.8M | $7.6M | $212.0K | $294.0K |
| Liabilities | ||||||||
| Accounts Payable | $13.0M | $12.4M | $11.7M | $9.8M | $8.9M | $8.2M | $3.8M | $2.8M |
| Total Current Liabilities | $87.7M | $76.4M | $64.9M | $75.0M | $19.7M | $10.7M | $50.8M | $26.1M |
| Long-Term Debt | $31.4M | $31.7M | $22.8M | — | — | — | — | — |
| Total Liabilities | $96.2M | $79.4M | $75.5M | $91.5M | $19.7M | $12.6M | $52.4M | $28.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-788.6M | — | — | — | — | — | — | — |
| Total Stockholders' Equity | $-67.3M | $-26.5M | $-4.7M | $-35.0M | $-9.8M | $-16.1M | $-52.2M | $-27.7M |